Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A
Status:
RECRUITING
Trial end date:
2026-11-17
Target enrollment:
Participant gender:
Summary
This trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.